Ameriprise Financial Inc. Lowers Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Ameriprise Financial Inc. cut its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 90.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,305,860 shares of the health services provider's stock after selling 12,218,119 shares during the quarter. Ameriprise Financial Inc. owned approximately 0.76% of Teladoc Health worth $11,870,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of TDOC. Vanguard Group Inc. lifted its holdings in Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after buying an additional 1,029,829 shares during the period. Renaissance Technologies LLC lifted its stake in shares of Teladoc Health by 15.5% during the 4th quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock worth $51,582,000 after purchasing an additional 763,265 shares during the last quarter. Geode Capital Management LLC boosted its position in Teladoc Health by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after purchasing an additional 22,664 shares in the last quarter. Maple Rock Capital Partners Inc. boosted its position in Teladoc Health by 189.5% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after purchasing an additional 2,331,000 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in Teladoc Health by 0.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,531,492 shares of the health services provider's stock valued at $32,104,000 after purchasing an additional 8,890 shares during the last quarter. Institutional investors own 76.82% of the company's stock.

Insider Buying and Selling at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the sale, the insider now owns 64,308 shares of the company's stock, valued at $541,473.36. This trade represents a 14.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.58% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on TDOC shares. Stifel Nicolaus lowered their price target on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a report on Thursday, May 1st. Piper Sandler lowered their target price on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, February 27th. Oppenheimer cut their price target on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a report on Friday, January 24th. Wells Fargo & Company decreased their price objective on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a report on Thursday, May 8th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Twelve investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $9.71.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $7.52 on Monday. Teladoc Health, Inc. has a 52 week low of $6.35 and a 52 week high of $15.21. The business's 50 day moving average price is $7.58 and its 200 day moving average price is $9.37. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm has a market cap of $1.32 billion, a P/E ratio of -1.30 and a beta of 1.82.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. On average, sell-side analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.